Scarica l'app Stockscreener
166.68
3.27%
-5.63
Dopo l'orario di chiusura:
166.68
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché A Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$172.31
Aprire:
$172
Volume 24 ore:
2.72M
Relative Volume:
1.21
Capitalizzazione di mercato:
$46.99B
Reddito:
$7.23B
Utile/perdita netta:
$1.41B
Rapporto P/E:
33.48
EPS:
4.979
Flusso di cassa netto:
$1.09B
1 W Prestazione:
-3.56%
1M Prestazione:
+11.17%
6M Prestazione:
+45.52%
1 anno Prestazione:
+20.28%
Intervallo 1D:
$166.07
$172.57
Intervallo di 1 settimana:
$166.07
$177.05
Portata 52W:
$108.35
$177.05
Agilent Technologies Inc Stock (A) Company Profile
Nome
Agilent Technologies Inc
Settore
Industria
Telefono
(408) 345-8886
Indirizzo
5301 STEVENS CREEK BLVD, SANTA CLARA, CA
Compare A vs TMO, DHR, NTRA, IQV
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
A
Agilent Technologies Inc
|
166.68 | 48.71B | 7.23B | 1.41B | 1.09B | 4.979 |
TMO
Thermo Fisher Scientific Inc
|
652.51 | 249.58B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
211.76 | 157.81B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
408.47 | 59.47B | 2.50B | -226.32M | 71.51M | -1.6412 |
IQV
Iqvia Holdings Inc
|
260.72 | 44.50B | 16.63B | 1.39B | 2.12B | 8.0674 |
Agilent Technologies Inc Stock (A) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-20 | Iniziato | HSBC Securities | Buy |
| 2026-01-05 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-12-15 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2025-12-09 | Iniziato | Goldman | Buy |
| 2025-12-02 | Iniziato | Morgan Stanley | Overweight |
| 2025-10-08 | Iniziato | Rothschild & Co Redburn | Buy |
| 2025-10-08 | Aggiornamento | UBS | Neutral → Buy |
| 2025-02-10 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-07-10 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-06-27 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2024-04-05 | Aggiornamento | Stifel | Hold → Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-12-12 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-11-17 | Downgrade | UBS | Buy → Neutral |
| 2023-09-28 | Iniziato | Bernstein | Mkt Perform |
| 2023-07-31 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-05-24 | Reiterato | Barclays | Equal Weight |
| 2023-05-24 | Reiterato | BofA Securities | Buy |
| 2023-05-24 | Reiterato | Citigroup | Neutral |
| 2023-05-24 | Reiterato | Credit Suisse | Outperform |
| 2023-05-24 | Reiterato | Evercore ISI | Outperform |
| 2023-05-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-24 | Reiterato | Robert W. Baird | Outperform |
| 2023-05-24 | Reiterato | SVB Securities | Outperform |
| 2023-05-24 | Reiterato | Stifel | Hold |
| 2023-05-24 | Reiterato | TD Cowen | Outperform |
| 2023-05-24 | Reiterato | Wells Fargo | Overweight |
| 2023-05-11 | Iniziato | Barclays | Equal Weight |
| 2023-01-10 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-07-20 | Iniziato | UBS | Buy |
| 2022-07-08 | Downgrade | Citigroup | Buy → Neutral |
| 2022-04-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-02-23 | Reiterato | BofA Securities | Buy |
| 2022-02-23 | Reiterato | Citigroup | Buy |
| 2022-02-23 | Reiterato | Cowen | Outperform |
| 2022-02-23 | Reiterato | Evercore ISI | Outperform |
| 2022-02-23 | Reiterato | Stifel | Hold |
| 2022-02-23 | Reiterato | Wells Fargo | Overweight |
| 2021-11-23 | Reiterato | BofA Securities | Buy |
| 2021-11-23 | Reiterato | Cowen | Outperform |
| 2021-11-23 | Reiterato | Stifel | Hold |
| 2021-03-18 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-02-17 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-12-02 | Iniziato | Goldman | Buy |
| 2020-11-25 | Aggiornamento | UBS | Neutral → Buy |
| 2020-11-17 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-09-30 | Iniziato | Atlantic Equities | Neutral |
| 2020-08-19 | Reiterato | BofA Securities | Neutral |
| 2020-08-19 | Reiterato | Citigroup | Neutral |
| 2020-08-19 | Reiterato | Jefferies | Buy |
| 2020-08-19 | Reiterato | Robert W. Baird | Outperform |
| 2020-08-19 | Reiterato | SVB Leerink | Outperform |
| 2020-08-19 | Reiterato | Stifel | Hold |
| 2020-08-19 | Reiterato | Wells Fargo | Overweight |
| 2020-02-24 | Downgrade | Needham | Buy → Hold |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Neutral |
| 2019-11-26 | Reiterato | Needham | Buy |
| 2019-11-15 | Iniziato | Stifel | Hold |
| 2019-10-18 | Downgrade | UBS | Buy → Neutral |
| 2019-07-16 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2019-07-15 | Downgrade | Barclays | Overweight → Equal Weight |
Mostra tutto
Agilent Technologies Inc Borsa (A) Ultime notizie
Agilent Introduces NovoStation Sample Prep System to Automate Flow Cytometry Workflows - Contract Pharma
$1000 Invested In Agilent Technologies 15 Years Ago Would Be Worth This Much Today - Benzinga
Why Is Medtronic (MDT) Down 6.4% Since Last Earnings Report? - Zacks Investment Research
Agilent Technologies (A) Launches NovoStation Automation System to Enhance Flow Cytometry Workflow - GuruFocus
A 30-sample lab process took 7.9 minutes of hands-on time with Agilent's system, versus 85.5 minutes manually. - Stock Titan
Agilent Technologies, Inc. (A) Stock Forecasts - Yahoo Finance
Agilent Technologies Inc. Introduces Agilent Biotek Gen5 Ai Cell Identification Module - marketscreener.com
Bullish on Agilent Technologies Inc - theglobeandmail.com
Agilent Ekes on Launch of BioTek - Baystreet.ca
Agilent launches AI cell identification software module - Investing.com
Agilent launches AI cell identification software module By Investing.com - Investing.com Canada
Agilent Introduces Gen5 AI Cell Identification Module for BioTek Automated Cell Imagers - Yahoo Finance
Agilent Technologies Inc. stock outperforms competitors on strong trading day - MarketWatch
Agilent Technologies Inc (A): GF Score of 96 Signals Strong Outp - GuruFocus
BofA Securities Maintains Agilent Technologies(A.US) With Buy Rating, Maintains Target Price $180 - Moomoo
Agilent Technologies stock follows a Q3 beat as targets diverge - AD HOC NEWS
Agilent Technologies (A) Tests Valuation On Exchange Offer And Recurring Revenue Story - Yahoo Finance
Agilent Technologies stock trades at USD 172.68 near its 52-week high - AD HOC NEWS
Agilent (A) Up 9.6% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Agilent Technologies stock gains 3.9 percent ahead of the open - AD HOC NEWS
Agilent Technologies Inc (A) Shares Surge 4.5% -- What GF Score of 93 Tells Investors - GuruFocus
Form 8K Agilent Technologies For: 24 September By Investing.com - Investing.com Canada
Why Agilent Technologies (A) Stock Is Up Today - Moomoo
Agilent Technologies stock hits 52-week high at 169.07 USD - Investing.com
Agilent Technologies stock reports 8.1 percent revenue growth - AD HOC NEWS
AGILENT TECHNOLOGIES, INC. SEC Filing (Sep 24, 2026) - Stock Titan
Agilent Technologies stock slips before the bell - AD HOC NEWS
If You Invested $1000 in Agilent Technologies a Decade Ago, This is How Much It'd Be Worth Now - Eastern Progress
Agilent Technologies Sees Growth From China, Replacement Cycles and Lab Automation - Yahoo Finance
Agilent Technologies Analysis: 3.29% Surge Highlights Strong Momentum - The Cryptonomist
Agilent Technologies at U.S. All Stars Conference: growth broadens By Investing.com - Investing.com Canada
Agilent Technologies at U.S. All Stars Conference: growth broadens - Investing.com
Why Did Agilent Technologies (A) Shares Climb After Its Latest Update? - Simply Wall Street
Agilent Technologies price pierces price targetForecast today22-09-2026 - Economies.com
Agilent Technologies stock gains 3.3 percent on strong results - AD HOC NEWS
Research Tools & Consumables Stocks Q2 Highlights: Agilent (NYSE:A) - TradingView
Agilent Technologies stock heads into the open after a 3.3% gain - AD HOC NEWS
Agilent Technologies Inc (A) Stock Up 3.5% but GF Value Says Ove - GuruFocus
Agilent Technologies stock gains on TapeStationDx launch and raised EPS guidance - AD HOC NEWS
Agilent Launches TapeStationDx Systems for Clinical NGS Sample Quality Control - BioSpace
Agilent launches clinical lab systems for DNA, RNA analysis By Investing.com - Investing.com Nigeria
Goldman Sachs Maintains Agilent Technologies(A.US) With Buy Rating, Raises Target Price to $185 - moomoo.com
Agilent launches clinical lab systems for DNA, RNA analysis - Investing.com
Goldman Sachs Adjusts PT on Agilent Technologies to $185 From $175, Maintains Buy Rating - moomoo.com
Agilent Technologies, Inc. (A) Stock Analysis: Unveiling a 11.81% Potential Upside in Diagnostics & Research - DirectorsTalk Interviews
Agilent Technologies stock heads into the open after a modest gain - AD HOC NEWS
Agilent Technologies stock rises on August 26 guidance lift - AD HOC NEWS
Agilent (A) Wants Pathology Labs To Go Digital, 540 Slides At A Time - Yahoo Finance
Agilent Technologies stock gains on fresh scanner launch and dividend - AD HOC NEWS
Is FDA Cleared Scanner Launch Altering The Investment Case For Agilent Stock? - simplywall.st
Agilent Technologies Inc. 2017 Q3ResultsEarnings Call Slides (NYSE:A) 2017-08-15 - Seeking Alpha
Agilent Technologies Inc Azioni (A) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.02%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):